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ABSTRACT 
 
 
Irrational use of drugs has a serious impact on health and the economy. The use 
of oral non-prescription drugs is increasing among university students 
worldwide. The objective of the present study is to measure the prevalence of 
use of oral-non-prescription drugs, assess appropriateness of this use, and 
identify factors associated with inappropriate use among students. A cross-
sectional study used anonymous self-administered questionnaire over the 
period of four months (January, 2014 to April, 2014). More than half (1348; 
57%) of participants reported the use of ONPD in the past 90 days before study 
commencement. Of 1,348, participants reported using ONPD; only 8% were 
inappropriate ONPD users for self-treating the last recent symptom. The present 
study identified three newly reported risk factors for the outcome. 
Polypharmacy behaviour was a significant predictor variable (OR = 2.457, 95% 
CI: 1.380-4.373, p=0.002), safety belief in the use of ONPD (OR= 1.702, 95% CI: 
1.070-ʹ.͹Ͳͻ, pζͲ.ͲͷȌ and medication knowledge ȋOR= Ͳ.͸Ͳͺ, ͻͷ% C): Ͳ.͵ͺͲ- 
 Ͳ.ͻ͹ʹ, pζͲ.ͲͷȌ. There is high prevalence of ONPD use among university students 
in UAE. However, the majority of this use was found to be appropriate. To 
promote healthy ONPD use in university students, awareness campaign is 
needed in all universities and must stress on the potential dangers of drug 
addict, drug abuse and polypharmacy behavior. 
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INTRODUCTION 
 
The appropriate use of NPDs in self-medication has 
multiple benefits for both the patient and the community. 
At the user level, appropriate self-medication with OTC-
drugs empowers people to take care of their own health 
(Huges et al., 2001; WHO, 2000; Ruiz, 2010). It is also a 
way of giving the patient fast and direct access to disease 
management, which can be particularly important in terms 
of contraception (Ruiz, 2010). Self-medication with NPD 
can provide quick pain relief until further medical 
evaluation is acquired (Ruiz, 2010; Pandya et al., 2013; 
Sharif and Sharif, 2014). 
 
The use of ONPDs is beneficial in terms of cost, 
particularly in countries that have a nationalized health 
service (Ruiz, 2010; Hughes et al., 2001). The prevalence of 
 
 
 
 
ONPDs use in self-medication practices among students at 
the university level is considered high across the world 
including United Arab Emirates (UAE) (Sawalha, 2008; 
Sharif et al., 2012; Pandya et al., 2013). One of the 
recommendations to reduce medication errors and harm is to use the ǲFive Rights ͷRǳ: the right patient, the right 
drug, the right dose, the right route and the right time 
(Federico, 2016; Grissinger, 2010). For safe and effective 
use of ONPDs, there are a number of tasks that must be 
performed by drug consumers that are usually carried out 
by a physician. These include: accurate self-diagnosis of 
the symptoms, appropriate selection of a drug along with 
the appropriate dosage and dosage schedule and 
consideration of multiple drug use (WHO, 2000). 
 Studies measured appropriate ONPDs use among 
students based on four criteria namely type of drugs, dose 
and frequency of use and duration of treatment (James et 
al., 2006, 2008). Other study measured appropriate drug 
use based on pharmacological indicators such as 
paracetamol appropriate to be used in fever, headache, 
general body pain, toothache or sore throat but 
unnecessary for other ailments (Sclafer et al., 1997). No 
study to date has explored inappropriate ONPD use among 
United Arab Emirates (UAE0 Higher Education Institution 
students). 
 
UAE students may be at risk of inappropriate ONPDs 
consumption because students in general have high rates 
of OTC-drug usage (Ali et al., 2010). The present study 
aims at measuring the prevalence of ONPDs use, assessing 
the appropriateness of this use and identifying risk factors 
associated with inappropriate ONPDs use among 
university students in UAE. 
 
 
MATERIALS AND METHODS 
 
Ethical consideration 
 
The present study was conducted after the approval of the 
institutional Ethics Committee in UAE and Gloucestershire 
University, UK. 
 
 
Study design 
 
A cross sectional study was conducted among the students 
of major universities in UAE from January to April, 2014. A 
multistage sampling technique was used in the present 
study. In step 1, three universities (out of five UAE 
universities that offer medical and non-medical programs) 
were randomly selected. In step 2, three medical and non-
medical colleges from each university were selected by 
stratifying on medical and non-medical colleges and then a 
simple random sampling technique was used to select one-
college from medical and two colleges from non-medical 
colleges within each university. In step 3, random sample 
from each year of program were selected using simple 
random table. 
 
Prior to participation in the study, all potential 
participants were informed about the aim of the study and 
their right to refuse participation or withdraw from the 
study. Students consent was taken before participating in 
the study. 
 
 
Study population 
 
Specified precision method was used to determine the 
sample size for this study. The desired level of confidence 
was set at 95% and the desired level of precision was set at 
0.03 on either side, such that the estimated proportion 
 
of inappropriate use was within 3% (for example, 47 to 
53%). The following formula is applied (Ali et al., 2010): 
 
n = (Z2 × P (1 – P))/e2 
 
Where Z = value from standard normal distribution 
corresponding to desired confidence level (Z=1.96 for 95% 
CI), P= expected true proportion, e = desired precision 
(half-desired CI width). 
 
A sample size of at least 1,068 ONPD users was needed. 
Assuming that the prevalence of ONPD use was 37.7% 
among students (Sawalha, 2008) to acquire 1,068 ONPD 
users, a total number of 2,833 students would be required. 
The present study distributed the questionnaire to 3,346 
students and identified 2,875 eligible students, giving a 
response rate of 85.9%. A total of 471 students were 
excluded, as they have had no prior experience ever with 
the use of ONPD. Furthermore, 356 students were 
unwilling to participate in the study and only 2,519 
students were identified as both ONPD user and non-user 
in the past 90 days before the study. Of 2,519 participants, ͳ͸Ͷ student’s surveys were excluded due to incomplete 
status or the fact that most of outcomes variables were not 
answered. Of 2,355 completed surveys, 1,007 respondents 
reported that that they have not used ONPD during the 
past 90 days before conducting the study. The remaining 
1,348 ONPD users in the past 90 days were collected and 
analyzed throughout the study period. 
 
 
Questionnaire development 
 
A self-administered questionnaire was used in this study. 
The questionnaire was constructed and developed based 
on Andersen behavioral model that guided the present 
study (Andersen and Newman, 1973). The questionnaire 
comprised of three types of questions divided into three 
categories: predisposing factors, enabling factors and need 
factors; accordingly, the survey ended up with more than 
40 explanatory variables. Independent variables were 
grouped into predisposing factors (3 demographic 
characteristics, 1 social structural characteristic and 15 
health belief characteristics), enabling factors (colleges, 
year of study, OTC- knowledge, medication knowledge, 
source(s) of ONPD - information, income and employment) 
and need factors (self-care orientation and perceived-
health). The survey was completed in a paper-and-pencil 
survey instead of an online form. The researcher provided 
a personal introduction and briefing of the study, 
informing the students of the nature of the study, the 
purpose of the study and the expected time to complete the 
questionnaire. All the students within the classes were 
invited to participate with informed consent, if they met 
three criteria: (1) being 18 years of age or older, (2) had 
previous experience using ONPD and (3) had not already 
taken the survey while attending another class. Based on 
this review, five assessment criterion were identified 
 namely self-diagnosis, self-selection of ONPD, dose, 
frequency of use and food-drug administration. 
 
In order to validate the assessment criteria of ONPD use, 
a panel of ten experts from an internationally accredited 
hospital in Dubai was selected. Four questions were used 
to test face -validity of the measuring instrument of the 
appropriateness of ONPD use and if the tool is valid to 
measure appropriateness of ONPD use and if there is any 
criteria must be added or removed from the tool. The panel 
members were informed of the nature, the purpose of the 
study and the expected time to answer the four questions. 
Informed consent to participate in the study was obtained. 
The panel agreed that the measuring instrument is face in 
that the tool is measuring what it supposed to measure. 
Then, eight out of ten participants agreed that the tool is 
content valid in that each item is clearly measuring the 
construct of interest and there is no additional criterion 
added to the tool. One university out of the three randomly 
selected universities was selected to conduct a pilot study 
to test the clarity of the survey. Pilot study was conducted 
over two steps and surveyed 100 students. In the first 
phase, 80 students across colleges at the target university 
were surveyed to determine the clarity and simplicity of 
the questions, the duration to answer the questionnaire 
and identify questions or response options that required 
modification or removal. After the survey was modified 
following the first phase, phase two was conducted where 
20 students were surveyed to assess the re-modified 
survey instrument. 
 
To determine inter-rater reliability of the measurement 
tool, two experts out of the ten experts who participated in 
the validation panel agreed to participate in the inter-rater 
reliability assessment. Each of the two physicians 
independently reviewed same 50 responses from the pilot 
study to determine the appropriateness of the ONPD use 
based on the five agreed upon criteria. The Kappa measure 
of agreement was 0.737, which represents good agreement 
between the two ratters (Howell, 2011). 
 
 
Data analysis 
 The participants’ responses were encoded for their 
demographic details; reasons for self-medication, 
commonly used ONPD, their knowledge, attitudes, beliefs 
and behaviors towards self-medication practice of ONPD. 
The data was analyzed using Statistical Package for the 
Social Sciences (SPSS, version 20, Chicago, IL, USA). 
Descriptive statistics was used to describe the study 
variables using frequencies and percentages. Chi-square 
test was used to identify any significant difference among the participants’ responses regarding certain statements in 
the questionnaire with a significant level of p<0.05. Binary 
Logistic Regression (BLR) was conducted to identify risk 
factors of inappropriate ONDP use and to compute odd 
ratio. 
 
RESULTS 
 
Only 2,355 surveys were returned completed and included 
in the study over the study period. Among the 2,355 
students participated in this study, the majority were 
females (1,797; 76.3%), single (2,151; 91.3%), and not 
employed during the study period (2,190; 93%). The 
majority of the participants (2,158; 91.6%) were at the age 
group of 18 to 23 years (Table 1). More than half (1,348; 
57.2%) of the participated students reported using ONPD 
in the past 90 days before conducting the study and were 
asked to complete the survey. 
 
The overwhelming majority (1,240; 91.9%) of the 
participants were appropriate ONPD users for self-treating 
the last recent symptom they experienced prior to the 
study. The highest proportion of inappropriate ONPD users 
violated only one assessment criterion (90.9%), of which 
more than half (59.2%) selected inappropriate drugs. Few 
of the inappropriate ONPD users (1.8%) violated three 
assessment criteria. Table 2 shows the distribution of the 
assessment criteria among inappropriate users (n=108). 
 
Headache was the most commonly reported symptom 
for nearly half of the ONPD users (626 of 1,348; 46.4%) 
followed by menstrual pain (203 of 1,348; 15.1%) and 
common cold (145 of 1,348; 10.8%). These symptoms are 
usually easy to self-diagnose which means that almost 
three-quarters of the users (72.3%; 974 of 1,348) satisfied 
the first criterion for appropriate drug use. 
 
Paracetamol (Panadol®) was the most commonly used 
drug (894 of 1,348; 66.3%), followed by, Ibuprofen, 
Brufen®, (141 of 1,348; 10.5%). Both of which are usually 
appropriate for treating most types of headache (BNF, 
2012: 285) and providing adequate pain relief of 
dysmenorrhoea (BNF, 2012: 268, 667); therefore, more 
than three-quarters of the users (76.7%; 1,035 of 1,348) 
satisfied the second criterion. The vast majority of 
paracetamol users also took only one tablet (500 mg); the 
recommended dose is 500 mg to 1 g (BNF, 2012: 270); 
two-thirds of the users (66%; 894 of 1,348) satisfied the 
third criterion. The overwhelming majority of the users 
took paracetamol only two to three times daily [can be 
taken every 4 to 6 h, if needed, to a maximum of 4 g in 
every 24 h (BNF, 2012: 270)]; two-thirds of the users 
(66%; 894 of 1,348) satisfied the fourth criterion. 
Regarding the fifth criterion (food-drug interaction), there 
is no recommendation that paracetamol be taken with or 
without food (FDA and NCL, 2013: 6; Bobroff et al., 2009: 
6); two-thirds of the users (66%; 894 of 1,348) therefore 
satisfied the fifth criterion. In summary, two-thirds of the 
users (66%; 894 of 1,348) used an ONPD appropriately to 
treat their most-recent symptom. 
 
Brufen® has to be taken after food to avoid stomach 
upset (FDA and NCL, 2013: 7; Bobroff et al., 2009: 7). A 
minority of users (1.3%; 18 of 1,348) used ONPD 
inappropriately, but they only violated the fifth criterion. 
Furthermore, antibiotics were used without prescription 
 Table 1: Demographic characteristics of the participants (n=2355). 
 
 
Demographics N Percentage (%) 
 95% CI 
Lower Upper 
    
Age      
18-20 1033 43.8  41.9 45.9 
21-23 1125 47.8  45.7 49.8 
24-26 171 7.3  6.2 8.4 
27-29 12 0.5  0.3 0.8 η͵Ͳ 14 0.6  0.3 0.9 
      
Gender      
Female 1797 76  74.6 78.0 
male 558 24  22.0 25.4 
      
Marital Status      
Single 2151 91.3  90.2 92.4 
Married 186 7.9  6.9 9.0 
Divorced 11 0.5  0.2 0.8 
Others 7 0.3  0.1 0.6 
      
Ethnicity      
UAE National 1073 45.5  43.5 47.6 
Arab 1068 45.4  43.4 47.4 
Asian 86 3.7  2.9 4.4 
Iranian 88 3.7  3.0 4.5 
Others 40 1.7  1.2 2.3 
      
Universities      
Sharjah University 681 28.9  27.0 30.8 
UAE University 837 35.5  33.6 37.5 
Ajman University 837 35.5  33.6 37.5 
      
Year of study      
1st year 175 7.4  6.4 8.5 
2nd year 560 23.8  22.1 25.5 
3rd year 713 30.3  28.5 32.2 
4th year 670 28.5  26.6 30.2 
5th year 190 8.1  7.0 9.2 
6th year 47 2  1.4 2.6 
      
Employment status      
Yes 165 7  5.9 8.1 
No 2190 93  91.9 94.1 
Total 2355 100  97.8 102.2 
 
 
for self-treating their most-recent symptom by only a very 
small proportion of the users (4.1%; 55 of 1,348); this 
makes them inappropriate users regardless of the other 
criteria. The number of users who reported using more 
than one ONPD for self-treating their most-recent symptom ȋpolypharmacyȌ was ǲextremelyǳ low ȋͳ.ͷ%; ʹͲ 
 
 
of 1,348). This extremely low rate of polypharmacy users 
decreases the possibility of drug-drug interactions 
dramatically (Koh et al., 2005; Rambhade et al., 2012) and 
also explains, at least in part, the high rate of appropriate 
ONPD users for the last recent symptoms. 
 
Binary  Logistic  Regression (BLR) was conducted to 
 Table 2: Distribution of the assessment criteria among inappropriate users (n=108). 
 
 
Assessment criteria Description Number Percentage 
 Inappropriate drugs 64 59.2 
One inappropriate criterion (n=98) Inappropriate food-drug administration 18 16.6 
(That is, the least inappropriate user) Inappropriate dose 10 9.2 
 Inappropriate frequency 6 5.5 
 
 
 
 
Two inappropriate criteria (n=8) (That 
is, the least inappropriate user) 
 
 
Inappropriate drug+ inappropriate food drug 3 2.7 
Inappropriate diagnosis + inappropriate drug 2 1.8 
Inappropriate dose+ inappropriate frequency 2 1.8 
Inappropriate dose+ inappropriate food-drug administration 1 0.9 
 
 
Three inappropriate criteria (n=2) (That 
is, moderate inappropriate users) 
 
Total 
 
 
Inappropriate drug +inappropriate dose +inappropriate 
2 1.8 
frequency 
  
 108 ͻͻ.ͷ≈ͳͲͲ% 
 
 
 
Table 3: Logistic regression model for associations with the least inappropriate ONPD use (n=1348). 
 
 
Variables Response Exp (B) OR  95% CI  p-value 
Polypharmacy behavior (ref-mono) Poly 0.463 1.589 1.024 2.465 0.039 
       
Safety belief in the use of ONPD (ref-disagree) 
Agree 0.532 1.702 1.070 2.709 0.025 
Uncertain -0.356 0.701 0.701 0.384 0.246 
 
       
Medication knowledge (ref-good) 
Poor 0.651 1.917 0.489 7.511 0.350 
Moderate -0.498 0.608 0.380 0.972 0.038 
 
 
 
assess the association of a number of factors on the 
likelihood that respondents would be the least 
inappropriate ONPD. The Hosmer and Leme show 
goodness of fit test was non-significant (p = 0.401), 
indicating a good model fit of the data. The statistically 
significant (p <0.001) Cox and Snell R2 (0.044) and 
Nagelkerke R2 (0.102) suggested that the predictive power 
of the model is modest. Within this model, three 
explanatory variables were statistically significant 
associated factors of inappropriate ONPD use 
(polypharmacy behavior, safety belief in the use of ONPD, 
and medication knowledge). 
 
Polypharmacy behavior was a significant predictor 
variable (OR = 2.457, 95% CI: 1.380-4.373, p=0.002). 
Therefore, participants who usually took more than one 
ONPD for self-treating a single symptom per day 
(polypharmacy behavior) had 1.5 times higher odds of 
being least inappropriate users than those who usually 
took only one ONPD a day (mono pharmacy). The odds 
ratio for participants agreed that ONPD are safe regardless 
of how frequently they are used with above 1 implying a 
positive relationship. Therefore, the odds of being least 
inappropriate ONPD users among participants had this 
incorrect believe about safety of ONPD are 1.7 times higher 
than participants who disagreed with the true population 
 
 
effect between 27 and 10%. This result was statistically 
significant (OR= 1.702, 95% CI: 1.070-ʹ.͹Ͳͻ, pζͲ.ͲͷȌ. 
 
Moderate level of medication knowledge was a 
protective factor against inappropriate ONPD use. The 
odds of being least inappropriate ONPD user among the 
response group of moderate medication knowledge are 
60% less than in reference group of good medication 
knowledge with the true population effect between 97 and 
38%, respectively. Table 3 shows that this result was statistically significant ȋpζͲ.ͲͷȌ. 
 
 
DISCUSSION 
 
The present study was conducted among the university 
students in UAE. The majority of the participants were 
females, which was found common in other studies 
conducted in UAE (Sharif et al., 2012). This study assessed participants’ appropriateness of use based on a five 
assessment criteria, which verified the accuracy of the 
drug taken. The most recent symptoms identified were 
headache, menstrual pain and finally common cold. All 
these symptoms are common among the general 
population and display characteristics that are easily 
identifiable. This may explain the high positive rate 
 achieved in this assessment. A total of 92% of the 
participants had five correct assessment criteria, which 
thus indicated that they had taken the right type of drug for 
the correct symptom. 
 
Results reported by this study are in contrast with 
previous literature, which shows that the prevalence of 
appropriate drug use is much smaller. For example, in 
Sudan Awad and Eltayeb (2007) reported only 20% 
appropriate drug use while James et al. (2006) reported a 
rate of 16%. The significant differences may be explained 
by methodological approaches as well as, by differences in 
the sample used. As previously indicated (Kjellsson et al., 
2014) bias can interfere with the accuracy of results, 
especially when a longer period of time has passed 
between the assessment period and the behavior analyzed. 
Some of the studies showing different results (Awad and 
Eltayeb, 2007; James et al., 2008, 2006; Sclafer et al., 1997) 
used longer recall periods which may have interfered with 
the results. Another difference between the current study 
and additional literature exploring the same topic is the 
sample used. 92% of the participants in this study 
demonstrated moderate-to-good levels of ONPD 
knowledge and 86% demonstrated moderate-to-good 
medication knowledge. 
 
Finally, another justification for the differences in results 
obtained by other research and the results of the current 
study may be connected with sample size. A significantly 
larger number of participants (n=1348) was used in this 
study by contrast with other research (James et al., 2006) 
(n = 134) and (James et al., 2008) (n = 141). Large samples 
are generally more representative of a target population by 
contrast with smaller samples (Howell, 2011; Tabachnick 
and Fidell, 2007). Therefore, our research incorporated 
more possible characteristics of the studied population, 
thus, avoiding data error through limiting the sample 
studied to only a small number of individual 
characteristics. 
 
Participants who engaged in polypharmacy behavior 
were also more likely to be inappropriate users. 
Participants who usually took more than one drug 
concurrently for self-treating a single symptom had a 
higher probability of being least inappropriate ONPD users 
than those who usually took only one drug daily. This 
expected result can be interpreted in several ways, using 
different drugs means using different active ingredients, 
which increases the possibility of drug to drug interactions. 
Furthermore, there is a possibility of using multiple drugs 
with different brand names but the same active 
ingredients, which increases the risk of exceeding the 
maximum recommended dose and also puts these 
participants at risk of being inappropriate ONPD users 
(Hughes, 2001; Hardon et al., 2004; Ruiz, 2010). 
 
Previous study (Mamun et al., 2004) with different 
targeted population also uncovered similar results in 
relation to polypharmacy and risk of inappropriate ONPD 
use. Considering that this research is over a decade old, the 
current study can be regarded as an update on the topic, 
 
demonstrating that the association between polypharmacy 
behavior and inappropriate drug use is consistent through 
time. 
 
Although 54% of our sample disagreed that ONPDs are 
safe to use regardless of frequency of use, the other half of 
the sample did not see ONPDs as dangerous. Because our 
study also shows significant levels of incautious ONPD use, 
such results under this variable were to be expected 
previous cross sectional investigations from UAE. Sharif 
and Sharif (2014) display similar findings as 20% of the 
university students (n=200) in UAE, believed that 
increasing drug dose cannot be dangerous (Sharif and 
Sharif, 2014). 
 
Another result we expected to find was that low levels of 
medication knowledge would result in more usage that is 
inappropriate. However, our finding showed that low-level 
of medication knowledge was not associated with the use 
of ONPD but rather the moderate- level. Therefore, having 
a moderate level of medication knowledge acted as a 
protective factor against the use of ONPD inappropriately. 
This finding suggests that students with adequate 
medication knowledge are using their drugs appropriately. 
Therefore, our study demonstrates that moderate level of 
medication knowledge is a power to use ONPD correctly and appropriately. To the best of the author’s knowledge, 
this is the first study to examine the relationship between 
medication knowledge and inappropriate drug use. 
However, our findings can be compared with other studies 
that investigated the associations between self-medication 
practices, yet, without connecting this with knowledge and 
appropriate use. These results are however contrasted by 
the study conducted by Auta et al. (2012) who found no 
statistically significant connection between the level of 
knowledge over ONPD and inadequate use. This contrast 
may be explained by using only the chi-square testing, the 
limited sample and the demographic characteristics of the 
participants. 
 
 
Conclusion 
 
There is high prevalence of ONPD use among university 
students in UAE. However, the majority of this use was 
found to be appropriate. To promote healthy ONPD use in 
university students, awareness campaign is needed in all 
universities and must stress on the potential dangers of 
drug addict, drug abuse and polypharmacy behavior. A 
compulsory course on rational use of medication should be 
inculcated in the syllabus in all disciplines of university 
courses. Further studies are required to investigate 
additional associated factors. 
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